476 related articles for article (PubMed ID: 11296263)
1. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.
Fassbender K; Simons M; Bergmann C; Stroick M; Lutjohann D; Keller P; Runz H; Kuhl S; Bertsch T; von Bergmann K; Hennerici M; Beyreuther K; Hartmann T
Proc Natl Acad Sci U S A; 2001 May; 98(10):5856-61. PubMed ID: 11296263
[TBL] [Abstract][Full Text] [Related]
2. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.
Simons M; Schwärzler F; Lütjohann D; von Bergmann K; Beyreuther K; Dichgans J; Wormstall H; Hartmann T; Schulz JB
Ann Neurol; 2002 Sep; 52(3):346-50. PubMed ID: 12205648
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
5. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.
Iijima K; Liu HP; Chiang AS; Hearn SA; Konsolaki M; Zhong Y
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6623-8. PubMed ID: 15069204
[TBL] [Abstract][Full Text] [Related]
7. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice.
Burns MP; Igbavboa U; Wang L; Wood WG; Duff K
Neuromolecular Med; 2006; 8(3):319-28. PubMed ID: 16775383
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol and Alzheimer's disease: a still poorly understood correlation.
Ricciarelli R; Canepa E; Marengo B; Marinari UM; Poli G; Pronzato MA; Domenicotti C
IUBMB Life; 2012 Dec; 64(12):931-5. PubMed ID: 23124820
[TBL] [Abstract][Full Text] [Related]
10. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin Efficiently Reduces Levels of Alzheimer's Amyloid Beta in Yeast.
Dhakal S; Subhan M; Fraser JM; Gardiner K; Macreadie I
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330953
[TBL] [Abstract][Full Text] [Related]
13. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease.
Hook V; Kindy M; Hook G
Biol Chem; 2007 Feb; 388(2):247-52. PubMed ID: 17261088
[TBL] [Abstract][Full Text] [Related]
14. The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease.
Hoglund K; Thelen KM; Syversen S; Sjogren M; von Bergmann K; Wallin A; Vanmechelen E; Vanderstichele H; Lutjohann D; Blennow K
Dement Geriatr Cogn Disord; 2005; 19(5-6):256-65. PubMed ID: 15785028
[TBL] [Abstract][Full Text] [Related]
15. The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.
Cibickova L; Hyspler R; Micuda S; Cibicek N; Zivna H; Jun D; Ticha A; Brcakova E; Palicka V
Steroids; 2009 Jan; 74(1):13-9. PubMed ID: 18817797
[TBL] [Abstract][Full Text] [Related]
16. Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease.
Carlsson CM; Gleason CE; Hess TM; Moreland KA; Blazel HM; Koscik RL; Schreiber NT; Johnson SC; Atwood CS; Puglielli L; Hermann BP; McBride PE; Stein JH; Sager MA; Asthana S
J Alzheimers Dis; 2008 Mar; 13(2):187-97. PubMed ID: 18376061
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin enhances learning and memory independent of amyloid load in mice.
Li L; Cao D; Kim H; Lester R; Fukuchi K
Ann Neurol; 2006 Dec; 60(6):729-39. PubMed ID: 17192930
[TBL] [Abstract][Full Text] [Related]
18. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
19. Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels.
Wahjoepramono EJ; Wijaya LK; Taddei K; Bates KA; Howard M; Martins G; deRuyck K; Matthews PM; Verdile G; Martins RN
Neuroendocrinology; 2011; 94(4):313-22. PubMed ID: 21985789
[TBL] [Abstract][Full Text] [Related]
20. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
Lam AR; Teplow DB; Stanley HE; Urbanc B
J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
